Anna Uddén

Master of Science from Uppsala University. Global Clinical Program Leader at Oncopeptides AB, Clinical study leader at Swedish Orphan Biovitrum AB and leading position within clinical development at, among other, Eli Lilly and Roche.

Contact information

Anna Uddén
V.P Clinical development strategy

E-mail: anna.udden@takura.se